This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Ovarian cancer continues to be a major life-threatening disease for women. Unfortunately, it responds only moderately to the current standard chemotherapy. The underlying reason for its insensitivity to chemotherapy is that ovarian cancer cells have many defense mechanisms to resist drug actions. Especially, they can effectively reduce the cell drug concentration by slowing the drugs entry into the cells, removing drugs out of the cells, and converting drugs into harmless forms. As a result, the drug concentration in cancer cells is too low to effectively kill them. Based on these facts, we propose that an instant release of a large amount of drugs into ovarian cancer cells would overwhelm the cancer cells defense mechanisms and build up a cell drug concentration much higher than the cell-killing threshold, and thus effectively kill the ovarian cancer cells. To test this hypothesis, the objective of the project is to develop and evaluate ovarian cancer-targeted and-activated instant-intracellular-drug-release (IIDR) nanoparticles for ovarian cancer chemotherapy. The designed IIDR nanoparticle can specifically accumulate in ovarian cancer tissues, enter the cancer cells effectively via several mechanisms, and instantly dump the drug into the cells. The resultant high drug concentration leads to effective cell-killing.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR016474-07
Application #
7610207
Study Section
Special Emphasis Panel (ZRR1-RI-7 (02))
Project Start
2007-05-01
Project End
2008-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
7
Fiscal Year
2007
Total Cost
$19,229
Indirect Cost
Name
University of Wyoming
Department
Type
Schools of Allied Health Profes
DUNS #
069690956
City
Laramie
State
WY
Country
United States
Zip Code
82071
Corda, Erica; Du, Xiaotang; Shim, Su Yeon et al. (2018) Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes ?-Cleavage of PrPC. Mol Neurobiol 55:7758-7774
Lindblom, Stormy D; Wangeline, Ami L; Valdez Barillas, Jose R et al. (2018) Fungal Endophyte Alternaria tenuissima Can Affect Growth and Selenium Accumulation in Its Hyperaccumulator Host Astragalus bisulcatus. Front Plant Sci 9:1213
Zhang, Yingmei; Ren, Jun (2018) Corrigendum to ""Thapsigargin triggers cardiac contractile dysfunction via NADPH oxidase-mediated mitochondrial dysfunction: Role of Akt dephosphorylation"" [Free Radic. Biol. Med. 51(12) (2011) 2172-2184]. Free Radic Biol Med 117:259-261
Jiang, Zhongliang; Jiang, Kun; McBride, Ralph et al. (2018) Comparative cytocompatibility of multiple candidate cell types to photoencapsulation in PEGNB/PEGDA macroscale or microscale hydrogels. Biomed Mater 13:065012
Jiang, Zhongliang; Xia, Bingzhao; McBride, Ralph et al. (2017) A microfluidic-based cell encapsulation platform to achieve high long-term cell viability in photopolymerized PEGNB hydrogel microspheres. J Mater Chem B 5:173-180
Young, Coleman H; Rothfuss, Heather M; Gard, Philip F et al. (2017) Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells. Reproduction 153:1-10
Wykes, Thomas L; Lee, Aaron A; Bourassa, Katelynn et al. (2017) Diabetes Knowledge Among Adults with Serious Mental Illness and Comorbid Diabetes Mellitus. Arch Psychiatr Nurs 31:190-196
Thomas, Jenifer J; Moring, John C; Harvey, Terra et al. (2016) Risk of type 2 diabetes: health care provider perceptions of prevention adherence. Appl Nurs Res 32:1-6
Edwards, Brian S; Dang, An K; Murtazina, Dilyara A et al. (2016) Dynamin Is Required for GnRH Signaling to L-Type Calcium Channels and Activation of ERK. Endocrinology 157:831-43
Kapali, Jyoti; Kabat, Brock E; Schmidt, Kelly L et al. (2016) Foxo1 Is Required for Normal Somatotrope Differentiation. Endocrinology 157:4351-4363

Showing the most recent 10 out of 325 publications